Literature DB >> 22953330

Bone marrow oxalosis.

Nasir A Bakshi1, Hazzaa Al-Zahrani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22953330     DOI： 10.1182/blood-2011-12-400192

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

Review 1.  Update on oxalate crystal disease.

Authors:  Elizabeth C Lorenz; Clement J Michet; Dawn S Milliner; John C Lieske
Journal:  Curr Rheumatol Rep       Date:  2013-07       Impact factor: 4.592

Review 2.  MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL.

Authors:  Manuela Tosi; Orietta Spinelli; Matteo Leoncin; Roberta Cavagna; Chiara Pavoni; Federico Lussana; Tamara Intermesoli; Luca Frison; Giulia Perali; Francesca Carobolante; Piera Viero; Cristina Skert; Alessandro Rambaldi; Renato Bassan
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

3.  Bone Marrow Oxalosis in a Patient With Pancytopenia Following Bilateral Nephrectomy.

Authors:  Moon Jin Kim; Pil Whan Park; Yiel Hea Seo; Kyung Hee Kim; Ja Young Seo; Ji Hun Jeong; Hwan Tae Lee; Jungsuk An; Jeong Yeal Ahn
Journal:  Ann Lab Med       Date:  2016-05       Impact factor: 3.464

4.  Plasma oxalate: comparison of methodologies.

Authors:  Felicity Stokes; Cecile Acquaviva-Bourdain; Bernd Hoppe; John C Lieske; Elisabeth Lindner; Greg Toulson; Frédéric M Vaz; Gill Rumsby
Journal:  Urolithiasis       Date:  2020-05-29       Impact factor: 3.436

Review 5.  Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?

Authors:  William P Martin; James White; Francisco J López-Hernández; Neil G Docherty; Carel W le Roux
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-17       Impact factor: 5.555
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.